INTERACTIONS BETWEEN THE GLUTAMATE AND GLYCINE RECOGNITION SITES OF THE N-METHYL-D-ASPARTATE RECEPTOR FROM RAT-BRAIN, AS REVEALED FROM RADIOLIGAND BINDING-STUDIES

被引:38
作者
GRIMWOOD, S
WILDE, GJC
FOSTER, AC
机构
[1] Merck Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex
关键词
GLYCINE; GLUTAMATE; NMDA RECEPTOR; H-3]L-689,560 BINDING; ALLOSTERIC INTERACTION;
D O I
10.1111/j.1471-4159.1993.tb13397.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The N-methyl-D-aspartate (NMDA) receptor possesses two distinct amino acid recognition sites, one for glutamate and one for glycine, which appear to be allosterically linked. Using rat cortex/hippocampus P2 membranes we have investigated the effect of glutamate recognition site ligands on [H-3]glycine (agonist) and (+/-)-4-trans-2-carboxy-5,7-dichloro-4-[H-3]phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline ([H-3]L-689,560; antagonist) binding to the glycine site and the effect of glycine recognition site ligands on L-[H-3]glutamate (agonist), DL-3-(2-carboxypiperazin-4-yl)-[H-3]propyl-1-phosphonate ([H-3]-CPP; ''C-7'' antagonist), and cis-4-phosphonomethyl-2-[H-3]piperidine carboxylate ([H-3]CGS-19755; ''C-5'' antagonist) binding to the glutamate site. ''C-7'' glutamate site antagonists partially inhibited [H-3]L-689,560 binding but had no effect on [H-3]glycine binding, whereas ''C-5'' antagonists partially inhibited the binding of both radioligands. Glycine, D-serine, and D-cycloserine partially inhibited [H-3]CGS-19755 binding but had little effect on L-[H-3]glutamate or [H-3]CPP binding, whereas the partial agonists (+)-3-amino-1-hydroxypyrrolid-2-one [(+)-HA-966], 3R-(+)cis-4-methyl-HA-966 (L-687,414), and 1-amino-1-carboxycyclobutane all enhanced [H-3]CPP binding but had no effect on [H-3]CGS-19755 binding, and (+)-HA-966 and L-687,414 inhibited L-[H-3]glutamate binding. The association and dissociation rates of [H-3]L-689,560 binding were decreased by CPP and D-2-amino-5-phosphonopentanoic acid (''C-5''). Saturation analysis of [H-3]L-689,560 binding carried out at equilibrium showed that CPP had little effect on the affinity or number of [H-3]L-689,560 binding sites. These results indicate that complex interactions occur between the glutamate and glycine recognition sites on the NMDA receptor. In addition, mechanisms other than allosterism may underlie some effects, and the possibility of a steric interaction between CPP and [H-3]L-689,560 is discussed.
引用
收藏
页码:1729 / 1738
页数:10
相关论文
共 47 条
[1]   [H-3] 5,7-DICHLOROKYNURENIC ACID, A NOVEL RADIOLIGAND LABELS NMDA RECEPTOR-ASSOCIATED GLYCINE BINDING-SITES [J].
BARON, BM ;
SIEGEL, BW ;
SLONE, AL ;
HARRISON, BL ;
PALFREYMAN, MG ;
HURT, SD .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 206 (02) :149-154
[2]   EVIDENCE FOR A FUNCTIONAL COUPLING OF THE NMDA AND GLYCINE RECOGNITION SITES IN SYNAPTIC PLASMA-MEMBRANES [J].
COMPTON, RP ;
HOOD, WF ;
MONAHAN, JB .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (01) :63-70
[3]   KYNURENATE AND 2-AMINO-5-PHOSPHONOVALERATE INTERACT WITH MULTIPLE BINDING-SITES OF THE N-METHYL-D-ASPARTATE-SENSITIVE GLUTAMATE RECEPTOR DOMAIN [J].
DANYSZ, W ;
FADDA, E ;
WROBLEWSKI, JT ;
COSTA, E .
NEUROSCIENCE LETTERS, 1989, 96 (03) :340-344
[4]  
DANYSZ W, 1989, MOL PHARMACOL, V36, P912
[5]   [H-3] D-SERINE LABELS STRYCHNINE-INSENSITIVE GLYCINE RECOGNITION SITES OF RAT CENTRAL NERVOUS-SYSTEM [J].
DANYSZ, W ;
FADDA, E ;
WROBLEWSKI, JT ;
COSTA, E .
LIFE SCIENCES, 1990, 46 (03) :155-164
[6]  
DONALD AE, 1988, BR J PHARM S, V96, pP892
[7]   CHLORIDE AND CALCIUM-IONS SEPARATE L-GLUTAMATE RECEPTOR POPULATIONS IN SYNAPTIC-MEMBRANES [J].
FAGG, GE ;
FOSTER, AC ;
MENA, EE ;
COTMAN, CW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 88 (01) :105-110
[8]   CGP-37849 AND CGP-39551 - NOVEL AND POTENT COMPETITIVE N-METHYL-D-ASPARTATE RECEPTOR ANTAGONISTS WITH ORAL ACTIVITY [J].
FAGG, GE ;
OLPE, HR ;
POZZA, MF ;
BAUD, J ;
STEINMANN, M ;
SCHMUTZ, M ;
PORTET, C ;
BAUMANN, P ;
THEDINGA, K ;
BITTIGER, H ;
ALLGEIER, H ;
HECKENDORN, R ;
ANGST, C ;
BRUNDISH, D ;
DINGWALL, JG .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (04) :791-797
[9]  
FAGG GE, 1988, NEUROL NEUR, V46, P59
[10]  
FOSTER AC, 1992, MOL PHARMACOL, V41, P914